Severe cholestasis related to itraconazole for the treatment of onychomycosis

American Journal of Gastroenterology

Volumn 94, Issue 12, 1999, Pages 3632-3633

  Talwalkar, Jayant A ^a   Soetikno, Roy E ^a   Carr Locke, David L ^a   Berg, Carl L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; ITRACONAZOLE;

AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; JAUNDICE; LIVER FUNCTION TEST; ONYCHOMYCOSIS; PRIORITY JOURNAL; PRURITUS;

AGED; ANTIFUNGAL AGENTS; BILIRUBIN; CHOLESTASIS, INTRAHEPATIC; HUMANS; ITRACONAZOLE; LIVER FUNCTION TESTS; MALE; ONYCHOMYCOSIS;

EID: 0032779118     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00682-6     Document Type: Article

References (4)

1. Lavrijsen A.P., Balmus K.J., Nutgteren-Huying W.M., et al. Hepatic injury associated with itraconazole. Lancet. 340:1992;251-252.
2. Hann S.K., Kim J.B., Im S., et al. Itraconazole-induced acute hepatitis. Br J Dermatol. 129:1993;500-501.
3. Tucker R.M., Haq T., Denning D.W., et al. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother. 26:1990;561-566.
4. Grant S.M., Clissold S.P. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycosis. Drugs. 37:1989;310-344.